Y học cổ truyền Trung Quốc đã mang lại những gì cho y học hiện đại?

Jigang Wang1, Yin‐Kwan Wong2, Fulong Liao1
1Artemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China
2Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore

Tóm tắt

Lĩnh vực Y học cổ truyền Trung Quốc (TCM) đại diện cho một nguồn tài nguyên rộng lớn và chủ yếu chưa được khai thác cho y học hiện đại. Được minh chứng bởi sự thành công của thuốc chống sốt rét artemisinin, những năm gần đây đã chứng kiến sự gia tăng nhanh chóng trong việc hiểu biết và ứng dụng các loại thảo dược và công thức có nguồn gốc từ TCM cho liệu pháp dựa trên bằng chứng. Trong đánh giá này, chúng tôi tóm tắt và thảo luận về lịch sử phát triển, bối cảnh lâm sàng và cơ sở phân tử của hành động cho một số loại thuốc tiêu biểu có nguồn gốc từ TCM như artemisinin, arsenic trioxide, berberine và Salvia miltiorrhiza (hay còn gọi là Danshen). Thông qua đó, chúng tôi làm nổi bật một số ví dụ quan trọng cho thấy cách mà các loại thuốc có nguồn gốc từ TCM đã đóng góp cho y học hiện đại, và thảo luận về những khả năng tiềm năng cho nghiên cứu trong tương lai.

Từ khóa


Tài liệu tham khảo

10.1021/acschembio.5b01043

Ji, 2000, Salvia miltiorrhiza and ischemic diseases, Acta Pharmacologica Sinica, 21, 1089

10.1371/journal.pone.0145109

10.1371/journal.pone.0060338

Jolliffe, 1993, A history of the use of arsenicals in man, Journal of the Royal Society of Medicine, 86, 287, 10.1177/014107689308600515

10.1200/JCO.2014.55.3453

Efferth, 2003, Molecular modes of action of artesunate in tumor cell lines, Molecular Pharmacology, 64, 382, 10.1124/mol.64.2.382

Sinclair, 2012, Artesunate versus quinine for treating severe malaria, Cochrane Database of Systematic Reviews, CD005967

10.1038/3030

Yang, 2012, Berberine improves insulin sensitivity by inhibiting Fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients, Journal of Evidence-Based Complementary and Alternative Medicine, 2012, 1

10.1016/j.jep.2008.07.011

10.1016/S0165-6147(00)89019-7

10.1016/j.bmc.2008.02.034

10.1155/2015/905749

10.1016/S0020-7519(02)00194-7

10.1093/jnci/90.2.124

Wang, 2016, An overview of systematic reviews of Danhong injection for ischemic stroke, Evidence-Based Complementary and Alternative Medicine, 2016, 8949835

10.1016/j.fitote.2010.08.019

10.1517/14656566.2012.677436

Li, 2007, Western-medicine-validated anti-tumor agents and traditional Chinese medicine, Trends in Molecular Medicine, 14, 1, 10.1016/j.molmed.2007.11.002

2015, Guidelines for the Treatment of Malaria, 32

10.1038/nm.2471

10.1155/2012/591654

10.1016/S0140-6736(08)61354-9

10.1016/j.ejphar.2015.04.017

Newman, 2012, Natural products as sources of new drugs over the 30 years from 1981 to 2010, Journal of Natural Products, 75, 311, 10.1021/np200906s

10.1016/S0165-6147(99)01302-4

10.1038/sj.onc.1204953

10.1038/nature01813

Tu, 2016, Artemisinin – a gift from traditional Chinese medicine to the world (Nobel Lecture), Angewandte Chemie (International ed. in English), 55, 10210, 10.1002/anie.201601967

10.1016/j.blre.2010.04.001

10.3390/molecules15031705

Looareesuwan, 1997, Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria, American Journal of Tropical Medicine and Hygiene, 56, 613, 10.4269/ajtmh.1997.56.613

10.1155/2015/646530

Bich, 1996, Efficacy and tolerance of artemisinin in short combination regimens for the treatment of uncomplicated falciparum malaria, American Journal of Tropical Medicine and Hygiene, 55, 438, 10.4269/ajtmh.1996.55.438

Griffin, 2016, Bloods 70th anniversary: arsenic--from poison pill to magic bullet, Blood, 127, 1729, 10.1182/blood-2015-10-638650

10.1038/sj.onc.1204762

10.1182/blood-2002-08-2654

10.1038/347558a0

10.1016/j.metabol.2008.08.013

10.1038/ncomms10111

Corson, 2007, Molecular understanding and modern application of traditional medicines: triumphs and trials, Cell, 130, 769, 10.1016/j.cell.2007.08.021

Efferth, 2015, Artemisinin – second career as anticancer drug?, World Journal of Traditional Chinese Medicine, 1, 2, 10.15806/j.issn.2311-8571.2015.0036

Wang, 2016, Publication process involving the discovery of artemisinin (Qinghaosu) before 1985, Asian Pacific Journal of Tropical Biomedicine, 6, 461, 10.1016/j.apjtb.2016.04.009

10.1016/j.metabol.2008.01.013

10.1371/journal.pone.0110124

10.1021/ja973080o

Huang, 1988, Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia, Blood, 72, 567, 10.1182/blood.V72.2.567.567

10.1006/excr.1999.4519

10.1007/s11655-014-1936-0

10.1016/S1387-1609(00)01188-9

10.1126/science.1168243

10.1002/hlca.19950780216

10.12659/MSM.881842

10.1086/516524

10.1053/meta.2002.34715

10.1021/ar100070k

10.1186/s12916-015-0445-x

Cheng, 2007, Cardiovascular effects of Danshen, International Journal of Cardiology, 121, 9, 10.1016/j.ijcard.2007.01.004

10.1007/s11427-013-4487-z

10.1016/S0140-6736(84)92057-9

Lo-Coco, 2013, Retinoic acid and arsenic trioxide for acute promyelocytic leukemia, New England Journal of Medicine, 369, 111, 10.1056/NEJMoa1300874

10.1073/pnas.0400053101

KJ, 2003, The integration of traditional Chinese medicine and Western medicine, European Review (Chichester, England), 11, 225

Xu, 2013, The quest for modernisation of traditional Chinese medicine, BMC Complementary and Alternative Medicine, 13, 1, 10.1186/1472-6882-13-132

Chan, 2010, Interactions between traditional Chinese medicines and Western therapeutics, Current Opinion in Drug Discovery and Development, 13, 50

Lee, 2006, Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states, Diabetes, 55, 2256, 10.2337/db06-0006

10.1016/j.tips.2005.09.006

10.1155/2013/153148

10.1016/j.bbagen.2013.02.008

Chen, 1986, Studies on the hypoglycemic effect of Coptis chinensis and berberine, Yao Xue Xue Bao, 21, 401

Geneva: World Health Organization (2016) World Malaria Report 2016. In World Malaria Report 2016 pp. 2.

10.1016/j.molmed.2007.07.001

10.1016/S0140-6736(04)15681-X

10.1016/0140-6736(92)90276-9

10.1126/science.3887571

1977, A new sesquiterpene lactone—Qinghaosu [in Chinese], Kexue Tongbao, 3, 142

1982, Chemical studies on Qinghaosu, Journal of Traditional Chinese Medicine, 2, 3

10.1182/blood-2005-10-4006

von Seidlein, 1998, A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children, American Journal of Tropical Medicine and Hygiene, 58, 638, 10.4269/ajtmh.1998.58.638

10.1016/S0035-9203(99)90376-0

10.1016/S0140-6736(10)61924-1

McIntosh, 2000, Artemisinin derivatives for treating severe malaria, Cochrane Database of Systematic Reviews, CD000527

10.3109/10408441003610571

10.1016/j.phymed.2012.08.011

10.1016/j.pharmthera.2013.12.001

Li, 2017, Artemisinins target GABAA receptor signaling and impair α cell identity, Cell, 168, 1, 10.1016/j.cell.2016.11.010

10.1002/anie.200604697

10.1210/jc.2007-2404

10.1073/pnas.1104063108

Fitch, 1983, Intracellular ferriprotoporphyrin IX is a lytic agent, Blood, 62, 1165, 10.1182/blood.V62.6.1165.1165

10.1016/j.jinorgbio.2007.12.004

10.1073/pnas.0500972102

10.1021/ar020227u

Loup, 2007, Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine, Antimicrobial Agents and Chemotherapy, 51, 3768, 10.1128/AAC.00239-07

10.1128/AAC.00165-08

10.1016/0006-2952(94)90287-9

Bhisutthibhan, 1998, The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin, Journal of Biological Chemistry, 273, 16192, 10.1074/jbc.273.26.16192

Kwong, 1997, Delicious poison: arsenic trioxide for the treatment of leukemia, Blood, 89, 3487, 10.1182/blood.V89.9.3487

Chen, 1996, In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins, Blood, 88, 1052, 10.1182/blood.V88.3.1052.1052

Chen, 1997, Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). I. As2O3 exerts dose-dependent dual effects on APL cells, Blood, 89, 3345

10.1038/sj.leu.2401900

Shen, 1997, Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients, Blood, 89, 3354, 10.1182/blood.V89.9.3354

10.1182/blood-2007-07-102798

10.1056/NEJM199811053391901

Niu, 1999, Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients, Blood, 94, 3315, 10.1182/blood.V94.10.3315.422k16_3315_3324

Jing, 1999, Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway, Blood, 94, 2102, 10.1182/blood.V94.6.2102

10.1038/sj.leu.2401650

Miller, 2002, Mechanisms of action of arsenic trioxide, Cancer Research, 62, 3893

Dai, 1999, Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system, Blood, 93, 268, 10.1182/blood.V93.1.268

Kapahi, 2000, Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase, Journal of Biological Chemistry, 275, 36062, 10.1074/jbc.M007204200

10.1002/cmdc.200700108

10.1053/shem.2002.33610

Dyck, 1994, A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein, Cell, 76, 333, 10.1016/0092-8674(94)90340-9

Melnick, 1999, Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia, Blood, 93, 3167, 10.1182/blood.V93.10.3167.410k44_3167_3215

Zhu, 2001, Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission, Oncogene, 20, 7257, 10.1038/sj.onc.1204852

10.1084/jem.193.12.1361

10.1016/j.ccr.2010.06.003

Zhang, 2010, Arsenic trioxide controls the fate of the PML-RAR alpha oncoprotein by directly binding PML, Science, 328, 240, 10.1126/science.1183424

10.1007/s13277-011-0259-1

de Thé, 2010, Acute promyelocytic leukaemia: novel insights into the mechanisms of cure, Nature Reviews Cancer, 10, 775, 10.1038/nrc2943

10.2174/157016310791162730

10.1371/journal.pone.0057604

10.1038/srep18111

Chung, 2016, Chinese herbal medicine for symptom management in cancer palliative care: systematic review and meta-analysis, Medicine (Baltimore), 95, e2793, 10.1097/MD.0000000000002793

10.1016/j.jep.2012.01.047

10.3816/CCC.2003.n.007

10.1007/s00280-013-2359-7

Tong, 2012, Treatment of diabetes using traditional Chinese medicine: past, present and future, American Journal of Chinese Medicine, 40, 877, 10.1142/S0192415X12500656

10.1016/j.jep.2003.12.031

10.1016/j.apsb.2012.06.003

Ni, 1988, Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research., Zhong Xi Yi Jie He Za Zhi (Chinese Journal of Modern Developments in Traditional Medicine), 8, 711

Pan, 2003, The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption, Planta Medica, 69, 632, 10.1055/s-2003-41121

Sun, 2005, Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction, Life Sciences, 76, 2849, 10.1016/j.lfs.2004.11.016

10.1517/13543784.2010.517745

Ji, 2013, Efficacy and safety of traditional Chinese medicine for diabetes: a double-blind, randomised, controlled trial, PLoS ONE, 8, e56703, 10.1371/journal.pone.0056703

10.1155/2012/184503

10.1016/j.phymed.2009.03.020

Wang, 2007, New developments in the chemistry and biology of the bioactive constituents of Tanshen, Medicinal Research Reviews, 27, 133, 10.1002/med.20077

Chan, 2004, Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against homocysteine-induced endothelial dysfunction, Life Sciences, 75, 3157, 10.1016/j.lfs.2004.06.010

Li, 2017, Toward a scientific understanding of the effectiveness, material basis and prescription compatibility of a Chinese herbal formula Dan-hong injection, Scientific Reports, 7, 46266, 10.1038/srep46266

10.1177/0091270005282630

10.1042/BST0390823

10.1038/aps.2010.24

10.1186/1423-0127-18-30

10.1016/j.jep.2014.08.023

10.1002/anie.201208749

Wang, 2016, Target identification of natural and traditional medicines with quantitative chemical proteomics approaches, Pharmacology and Therapeutics, 162, 10, 10.1016/j.pharmthera.2016.01.010

10.1016/j.ebiom.2014.11.010

Posner, 1994, Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity, Journal of Medicinal Chemistry, 37, 1256, 10.1021/jm00035a003

10.1016/j.jep.2014.09.049

Li, 2016, Characterization of the artemisinin binding site for translationally controlled tumor protein (TCTP) by Bioorthogonal Click Chemistry, Bioconjugate Chemistry, 27, 2828, 10.1021/acs.bioconjchem.6b00556

2017, Recommendations on the clinical use of compound Danshen dripping pills, Chinese Medical Journal (England), 130, 972